Clinical Trials Logo

Virus Diseases clinical trials

View clinical trials related to Virus Diseases.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT03824847 Suspended - Influenza, Human Clinical Trials

Immunomodulatory Effect of Macrolides in Naturally Occurring Influenza Virus Infections in the Community

Start date: June 1, 2023
Phase: Phase 4
Study type: Interventional

The investigators propose a double-blind randomised placebo-controlled study in naturally occurring influenza virus infections in the community setting to compare the impact of a short course of clarithromycin versus placebo, on the clinical course, viral shedding, immunomodulation, and the antimicrobial resistance pattern of respiratory bacterial carriage of the patients.

NCT ID: NCT03462004 Suspended - Ebola Virus Disease Clinical Trials

Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein

Start date: March 5, 2018
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, infectivity, and immunogenicity of two doses of the HPIV3/ΔHNF/EbovZ GP vaccine candidate when administered intranasally in healthy adults.

NCT ID: NCT02391467 Suspended - Clinical trials for Hepatitis B Virus Infection; Pregnant Women

Validity of Elastography During Pregnancy

Start date: December 2014
Phase: N/A
Study type: Observational [Patient Registry]

Non invasive methods are the only available methods to stage liver fibrosis during pregnancy. The safety of elastometry - ultrasound based - is obvious, as medical supervision of pregnancy is based on ultrasonography, both methods using same wavelengths. Therefore, this method is sometimes used in pregnant women with recent diagnosis of chronic viral hepatitis infection, whereas its validity in pregnant women has never been studied. This lack of data justifies our study.

NCT ID: NCT00186927 Suspended - Parainfluenza Clinical Trials

A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers

Start date: May 5, 2005
Phase: Phase 1
Study type: Interventional

Croup is an illness of young children that is caused by a virus. With this illness, the child has fever, cough, and hoarseness. Although the illness usually gets better in 2 to 4 days, some children may be admitted to the hospital and a few infants may require an intervention to help their breathing. This illness is most often caused by a virus called parainfluenza virus type 1, but it can be caused by other viruses. The experimental vaccine that is being investigated in this study is intended to try to prevent croup caused by parainfluenza virus type 1. Currently, there are no vaccines to prevent this virus, or medications available to treat the illness once infection has occurred. This research study is testing a new experimental live-virus vaccine that is given by placing liquid drops in the nose. The Sendai virus is very similar to the virus that causes croup, but it has never been found to cause illness in people. Previous studies in animals have shown that the vaccine provided protection against the croup virus, and did not cause illness. Many people have been exposed to the Sendai virus, but no one has been known to develop illness. Several healthy adults have been given the Sendai virus vaccine being studied, and they did not experience any serious side effects or illness.